Abstract:Background and objective: Raised blood lactate secondary to high dose β2 -agonist treatment has been reported in asthma exacerbations but has not been investigated during acute exacerbations of COPD (AECOPD). We explored associations of blood lactate measurements with disease outcomes and β2 -agonist treatments during AECOPD. Methods: Retrospective (n = 199) and prospective studies (n = 142) of patients hospitalized with AECOPD were conducted. The retrospective cohort was identified via medical records and the prospective cohort was recruited during hospitalization for AECOPD. Baseline demographics, comorbidities, β2 -agonist treatment, biochemical measurements and clinical outcomes were compared between patients with normal (≤2.0 mmol/L) versus elevated lactate (>2.0 mmol/L). Regression analyses examined associations of lactate measurements with β2 -agonist dosages. Results: Demographic data and comorbidities were similar between high versus normal lactate groups in both cohorts. The populations were elderly (mean >70 years), predominantly male (>60%) with reduced FEV1 (%) 48.2 ± 19 (prospective cohort). Lactate was elevated in approximately 50% of patients during AECOPD and not related to evidence of sepsis. In the prospective cohort, patients with high lactate had more tachypnoea, tachycardia, acidosis and hyperglycaemia (p < 0.05) and received more non-invasive ventilation (37% vs. 9.7%, p < 0.001, prospective cohort). There was a trend to longer hospitalization (6 vs. 5 days, p = 0.06, prospective cohort). Higher cumulative β2 -agonist dosages were linked to elevated lactate levels (OR 1.04, p = 0.01). Conclusion: Elevated lactate during AECOPD was common, unrelated to sepsis and correlated with high cumulative doses of β2 -agonists. Raised lactate may indicate excessive β2 -agonist treatment and should now be investigated as a possible biomarker.

A Preliminary Investigation of Exploration-Oriented, Learning Behaviors for Managing Project Quality

The 2016 American Academy of Ophthalmology IRIS® Registry (Intelligent Research in Sight) Database: Characteristics and Methods.

Severe lactic acidosis and persistent diastolic hypotension following standard dose of intermittent nebulized salbutamol in a child: a case report

Adverse effects of short-acting beta-agonists: potential impact when anti-inflammatory therapy is inadequate

Effects of Terbutaline and Budesonide on Sputum Cells and Bronchial Hyperresponsiveness In Asthma

Placental Growth Factor Influences Maternal Cardiovascular Adaptation to Pregnancy in Mice1

Adrenal tea leaves: Is the adrenal response to sepsis discernible?

[Comparison of Different Vehicles for Nebulized Salbutamol in Treatment of Bronchial Asthma Exacerbations: a Meta-analysis].

Computed cardiopulmonography: Effects of salbutamol in healthy individuals versus patients with asthma

Asthma: effect of excess short-acting {beta}2-agonist (SABA) inhaler prescriptions on healthcare resource utilisation

Cardiogenic pulmonary edema following β2 agonist infusion for acute bronchospasm

Mucociliary clearance in patients with chronic asthma: effects of beta agonists

Biochemical changes in rat liver after administration of carbon disulphide, with particular reference to microsomal changes.

Repeated dose budesonide/formoterol compared to salbutamol in adult asthma: A randomised cross-over trial

Efficacy and safety of budesonide/formoterol compared with salbutamol in the treatment of acute asthma

Elevated blood lactate in COPD exacerbations associates with adverse clinical outcomes and signals excessive treatment with β2 -agonists

Evaluation of different nebulized bronchodilators on clinical efficacy and hypokalemia in asthmatic children

Beta-adrenoceptor agonists and asthma--100 years of development

Efficacy and side effects of beta 2-agonists by inhaled route in acute asthma in children: comparison of salbutamol, terbutaline, and fenoterol

Diagnosis and prediction of pediatric HIV‐1 infection and AIDS: Current status

Overprescription of short-acting β 2 agonists: reflections from the SABINA study in Brazil